MI-mAbs (@MI_mAbs) header
MI-mAbs (@MI_mAbs) profile picture
Marseille, France
Joined March 2019
Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)Photo by MI-mAbs (@MI_mAbs)
The @US_FDA granted accelerated approval to #Trodelvy #sacituzumabgovitecan-hziy, the first #AntibodyDrugConjugate that targets Trop-2, for treatment of #mTNBC #BreastCancer bit.ly/2XYzOLW
MI-mAbs retweeted
CP : médicaments de thérapie innovante : une filière dynamique et bien implantée en France avec 36 sociétés. => ow.ly/mb7Y50yqflE
#MIDay #LungCancer "In the #clinic, the bigger the team, the higher the chances of success for #patients" @Barlesi @univamu @GustaveRoussy @immunopole
3
6
🔬 #Marseille est une des capitales mondiales de la recherche contre le #cancer, en particulier en immuno-oncologie. Pour le #MIday, jeudi, un comité d’experts répond au public et décortique 10 idées reçues sur le cancer du poumon. Les détails ➡️ tinyurl.com/vwvh36m
15
22
À l’initiative de @barlesi #MIday #LungCancer le 6 février 2020 à Marseille avec @Immunopole @aphm_actu @APHMphaseIonco @univamu #RMCMOT @CanceropolePACA @Fr_Assos_Sante @AstraZenecaFR @HalioDx @InnatePharma @PoleEurobiomed Programme et inscriptions : bit.ly/2RUa3rl
1
18
3
26
MI-mAbs retweeted
Join our #WEBINAR: “State of the art ADC validation” hosted by #FlorenceLHospice and #FrançoisRomagné on Friday, January 31st, 2020 at 11:30 am CET. Register to the webinar : register.gotowebinar.com/reg…
5
5
MI-mAbs retweeted
Replying to @laurentpouyet
@Laurentpouyet's presentation : « A wide toolbox to maximise translational relevance of #preclinical studies involving mAb #immunotherapies » at #PredictTumourModel (4-6 Dec, London) mimabs.org/upcoming-event
3
2
MI-mAbs retweeted
Come and meet @MI_mAbs team on booth #3 at the Festival of Biologics #FOB2019. Don't miss our presentation "Use of monoclonal #antibodies for therapeutic purposes necessitates a careful choice of subclasses and isotypes to fulfil the desired functional effect #invivo" @Terrapinn
4
4
MI-mAbs retweeted
Come and meet @MI_mAbs 's team at #EBDC2019 (25 to 26 Sept) in #Heidelberg and don't miss the presentation of @AgnesMenut (on Thursday, 26 September) biodeutschland.org/en/europe…
2
2
MI-mAbs retweeted
Meet us at the 4th Edition #Bioproduction of #Immunotherapies on Sept 24 in @93Romainville and dont miss #StephanieBlanchin presentation "Bioproduction of therapeutic antibodies in CHO cells, always the “gold standard”" mimabs.org/upcoming-events/ @MabDesign_fr @Pole_Medicen
2
1
Five scientists honored for cancer therapy, immune system work medicalxpress.com/news/2019-…
1
4
9
MI-mAbs retweeted
[#Brève] Une équipe internationale de chercheurs vient de mettre au point une #thérapie ciblée qui pourrait permettre réduire la taille des #tumeurs, là où les médicaments précédents ont échoué. ➡️ bit.ly/therapietumeurs
#Nrp1 works as a negative regulator of #antitumoural activities of a subset of #CD8Tcells - an #ImmuneCheckpoint with therapeutic potential. A paper by #FatiaMamiChouaib et al @NatureComms | go.nature.com/31dm6TV
Hommage Michel Pierres (1946-2019) @Insermpacacorse @CNRS_dr12 @univamu @Immunopole @MI_mAbs ciml.univ-mrs.fr/fr/actualit…
2
4
MI-mAbs retweeted
Come and meet #FrançoisRomagné and #FrédériqueLembo of @MimAbs at #7AIS2019 (@congress_ais)- June 24-25, 2019 in #Tours to #Harnessing the #immunesystem with #therapeutic #antibodies. Don’t miss our poster presentation. mimabs.org/upcoming-event/ev… @mabdesign @MabImprove
4
4
Bad news for all of us #MichelPierres, world class #Immunologist, former Director of @CIML_Immunology (1991-1994), French pioneer of #AntibodyTechnology and true polymath, died last night
1
14
1
12
A lire dans @pelerincom, article de @Estelle_Co "L'#Immunothérapie, une nouvelle arme contre le cancer" avec @EricVivier1
6
9
Come & meet @MI_mAbs at #BIO2019 booth #2109. @MI_mAbs, an #innovative #immunotechnology platform that accelerate the development of #mAbs, #ADCs an #bispecifics in the #oncology and #inflammation fields. #SouthOfFranceAtBIO19 @FrencHealthcare @BF_HealthcareNA #FrenchPavilion
1
2